BIT's 7th Annual World Congress of Molecular & Cell Biology (CMCB-2017)
★ Exhibition

This conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you.


Some companies have been thinking of ways that events can help their business, let me show you the 6 ways that you will benefit from this grand event.


1. Position your product
Smart marketers spend a lot of time deciding how to "position" their products or services in the consumer's mind. If you DO choose the right positioning for your product or service, and communicate it forcefully to your target audience, you can ultimately build a strong brand identity that can have enduring value.


2. Brand exposure
With the quality and number of visitors in attendance, exhibiting at this conference gives you brand exposure to the sort of people who will actually buy your services. Remember, being in the same room as your competitors only increases brand awareness if your customers are there to see you.


3. Networking
This conference will extend business, networking and learning opportunities beyond the event venue and successfully acts as a bridge between China and the international market.


4. Connections
It is not only a conference but also a platform that you can meet your clients, prospects and friends or seek potential business opportunity.

5. An ideal medium
It is an ideal medium for test marketing or launching new products. New buying interests can be uncovered and otherwise unaccessible buyers appear in front of your exhibit.

6. Concessions to returned exhibitors
We will give a discount to our regular exhibitors from 10% to 20%. If this is the first conference, we will encourage potential exhibitors to attend this event by some concessions.

Any questions or information about exhibiting at this conference, please do not hesitate to contact:

Ms. Judy Du
Organizing Committee of CMCB-2017
BIT Congress Inc.
East Wing, 11F, Dalian Ascendas IT Park,
No. 1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, P.R.China
Tel: 0086-411-84799609-839
Fax: 0086-411-84799629

Email: Judy@cmcb-congress.com

China Local Time


Days to Go!


News Released

● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
REGISTER NOW to secure your attendance
Scientific Program has been released
● Call for collaborative partners, media and journal

New Speakers Confirmed

Dr. Franz E. Weber, Professor, University of Zurich, Switzerland
Dr. Dongping Zhong, Professor, The Ohio State University, USA
Dr. Mark A. Birch-Machin, Professor, Newcastle University, UK
Dr. Gong Chen, Professor, Pennsylvania State University, USA
Dr. Giulio Filippo Tarro, President, Foundation de Beaumont Bonelli for Cancer Research, Italy
Dr. Roman A. Zubarev, Professor, Karolinska Institutet, Sweden
Dr. Yonggui Gao, Associate Professor, Nanyang Technological University, Singapore
Dr. Kiwon Song, Associate Professor, Yonsei University, South Korea
Dr. Yasuo Iwasaki, Professor, Toho University, Japan
Dr. Yong Zhou, Associate Professor, University of Alabama at Birmingham, USA
Dr. Huangui Xiong, Professor, University of Nebraska Medical Center (UNMC), USA
Dr. Gregory Lee, Professor, University of British Columbia, Canada
Dr. Pavel Hozak, Head, Laboratory of Biology of the Cell Nucleus & IMG Microscopy Centre, Czech Republic
Dr. Patrick van Rijn, Assistant Professor, University of Groningen, The Netherlands
Dr. Shetuan Zhang, Professor, Queen’s University, Canada
Dr. Vita Dolžan, Professor, Faculty of Medicine, University of Ljubljana, Slovenia
Dr. Kazushi Kimura, Professor, Hokkaido Bunkyo University, Japan
Dr. Hana Zelenkova, Head, Private Clinic of  Dermatovenerology – DOST Svidnik, Slovakia
Dr. Xingming Fan, Researcher, Yunnan Academy of Agricultural Sciences, China
Dr. Daniel Aberdam, Director, INSERM U976, Université Paris-Diderot, France
Dr. Jean Gabert,Professor, Aix marseille University, France
Dr. Panagiotis Bouras, General Surgeon & Researcher, Nikaia General Hospital Piraeus, Greece
Dr. Ichiro Maruyama, Professor, Okinawa Institute of Science and Technology Graduate University, Japan
Dr. Takuya Aoki,Associate Professor, Tokai University School of Medicine, Japan
Dr. Robert Plumb, Professor, Imperial College London, UK
Dr. Yuan-Sung Kuo, National Taiwan University Hospital, Taiwan
Dr. Alice Yu, Distinguished Chair Professor, Chang Gung Memorial Hospital, Taiwan
Dr. John Yu, Distinguished Chair Professor, Chang Gung Memorial Hospital, Taiwan
Dr. KaljuPaju,Associate Professor, Tartu University, Estonia
Dr. Pal Ormos, Director General, Biological Research Centre, Hungarian Academy of Sciences, Hungary
Dr. Alessia Annibale, Lecturer, King’s College London, UK
Dr. Sanne Schoffelen, Assistant Professor, University of Copenhagen, Demark
Dr. Jia-Ching Shieh, Associate Professor, Chung Shan Medical University, Taiwan
Dr. Ivan Vorobyev, Professor, M.V. Lomonosov Moscow State University, Russian
Dr. Junjie Yang, Professor, Soochow University, China
Dr. Tengchuan Jin, Professor, University of Science and Technology of China, China
Dr. Yan-Wen Tan, Professor, Fudan University, China
Dr. Zvi Naor, Professor, Tel Aviv University, Israel
Dr. Jukka Tuomi, Research Director, Aalto University, Finland

Honorary Chair

Dr. Yuxin Yin,
Dean & Director, Peking University, China


Yuxin Yin
Dr. Yuxin Yin is Dean in School of Basic Medical Sciences, Director in Institute of Systems Biomedicine, Peking University Health Science Center, Peking University, China
Dr. Yin received his Ph.D. in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill in 1997 and got postdoctoral training in Princeton University. In 1999, he was appointed as a tenure-track Assistant Professor in Columbia University and was promoted to the Associate Professor in 2007. He was recruited as a National One-thousand Talent Plan to the Peking University Health Science Center in 2010. His research field is cancer research with focus on the roles of tumor suppressors p53 and PTEN in cell cycle regulation, apoptosis and genomic stability. He was the first one to find a fundamental role for p53 in maintaining genomic stability (Cell). Also, it is first reported that PTEN plays a fundamental role in the maintenance of chromosome stability (Cell). In Peking University, Dr. Yin has made great progress in studying the PTEN pathway in genome stability and tumor suppression. Recently, his group revealed a novel mechanism of alternative translation of protein and discovered a new member of the PTEN protein family named PTENα (Cell Metabolism). These studies may provide new insights into the mechanism by which PTEN maintains genomic stability and suppresses tumorigenesis.

Hosting Organization
whtslogo.JPG
World High-Tech Society
Operating Organizations

Zhen-Ao Group


SHUANGDI, INC.

BIT Group Global Ltd.

Supporting Organizations




The Argentine Genetics Society (SAG) 

Official Travel Agency

BIT World Travel Service, Inc.

Media Partners
http://4tsconference.com/#home
http://dnaday.com/images/media/Media%20Partner%20List_clip_image003.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image005.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image007.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image009.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image011.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image013.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image015.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image017.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image019.jpg
http://dnaday.com/images/media/Media%20Partner%20List_clip_image020.jpg
http://www.dnaday.com/images/52untitled.jpg
BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411- 84799609-839, Fax: 0086-411-84799629
Copyright © 2014-2015 BIT Congress Inc.